BRCA1 INVOLVED 2 WAYS IN SPORADIC CANCERS

被引：0
|
作者：
ROWE, PM
机构：
来源：
LANCET | 1995年 / 345卷 / 8954期
关键词：
D O I：
10.1016/S0140-6736(95)90027-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：917 / 917
页数：1
相关论文
共 50 条
  • [21] More about: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations - Response
    Brown, DL
    Cole, BF
    Arrick, BA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (16) : 1422 - 1422
  • [22] Pathology of ovarian cancers in BRCA1 and BRCA2 carriers
    Lakhani, SR
    Manek, S
    Penault-Llorca, F
    Flanagan, A
    Arnout, L
    Merrett, S
    McGuffog, L
    Steele, D
    Devilee, P
    Klijn, JGM
    Meijers-Heijboer, H
    Radice, P
    Pilotti, S
    Nevanlinna, H
    Butzow, R
    Sobol, H
    Jacquemier, J
    Lyonet, DS
    Neuhausen, SL
    Weber, B
    Wagner, T
    Winqvist, R
    Bignon, YJ
    Monti, F
    Schmitt, F
    Lenoir, G
    Seitz, S
    Hamman, U
    Pharoah, P
    Lane, G
    Ponder, B
    Bishop, DT
    Easton, DF
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2473 - 2481
  • [23] Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
    Sunil R Lakhani
    Kum Kum Khanna
    Georgia Chenevix-Trench
    Breast Cancer Research, 12
  • [24] Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
    Lakhani, Sunil R.
    Khanna, Kum Kum
    Chenevix-Trench, Georgia
    BREAST CANCER RESEARCH, 2010, 12 (02)
  • [25] Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
    Lakhani, SR
    Easton, DF
    Stratton, MR
    StorferIsser, A
    Anderson, TJ
    Farid, LM
    Gusterson, BA
    Jaquemier, J
    Sloane, JP
    Venter, D
    VandeVijver, MJ
    Bishop, DT
    Barkardottir, RB
    Bignon, YJ
    Cornelisse, C
    ChangClaude, J
    Daly, PA
    Devilee, P
    Egilsson, V
    Ford, D
    Goldgar, D
    Haites, N
    Hamann, U
    Klijn, JGM
    Lasset, C
    Lenoir, G
    McManus, R
    Neuhausen, S
    Ormiston, W
    Ponder, BAJ
    Peto, J
    Steel, CM
    StoppaLyonnet, D
    Smyth, E
    Sobol, H
    Spurr, NK
    Scott, RJ
    Scherneck, S
    Streuwing, JP
    Vasen, H
    Weber, B
    LANCET, 1997, 349 (9064): : 1505 - 1510
  • [26] BRCA1/2 reversion mutations as a mechanism of acquired drug resistance in BRCA1/2-mutated cancers
    Taniguchi, Toshiyasu
    CANCER SCIENCE, 2023, 114 : 260 - 260
  • [27] BRCA1 and BRCA2 mutation screening in sporadic and familial breast cancer
    Ellis, D
    McCall, SH
    Greenman, J
    Evans, G
    Abbs, S
    Hodgson, SV
    Mathew, CG
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S38 - S38
  • [28] Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma
    Kim, YT
    Nam, EJ
    Yoon, BS
    Kim, SW
    Kim, SH
    Kim, JH
    Kim, HK
    Koo, JS
    Kim, JW
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 585 - 590
  • [29] Novel therapeutic approaches for BRCA1 and BRCA2 associated cancers
    Tutt, Andrew
    JOURNAL OF MEDICAL GENETICS, 2006, 43 : S37 - S37
  • [30] PROGNOSIS OF BRCA1 AND BRCA2-RELATED BREAST CANCERS: ARE THERE DIFFERENCES?
    Ballatore, Z.
    Pistelli, M.
    Bracci, R.
    Bianchi, F.
    De Lisa, M.
    Napolitano, M.
    Pagliacci, A.
    Battelli, N.
    Ridolfi, F.
    Maccaroni, E.
    Santinelli, A.
    Biscotti, T.
    Berardi, R.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2014, 25
12345